EACR Liquid Biopsies

Topics to be covered include the implementation of liquid biopsies in clinical trials, the various applications for CTCs, the basic biology of biomarker discovery, new techniques enhancing liquid biopsy, the integration of multiple blood-based analytes for multimodal biomarkers, and how artificial intelligence can be applied to the field. 

This conference is suitable for a wide audience including translational scientists, researchers working in genetics, biology, molecular pathology, bioengineering, and data science, as well as clinical and non-clinical trainees, primary care physicians, radiologists, patient advocates, and colleagues from industry working in biotechnology, diagnostics, and pharmaceuticals. 

Speakers: Nicola Aceto (ETH Zurich, Switzerland), Valsamo Anagnostou (Johns Hopkins University School of Medicine, USA), Johann De Bono (ICR, UK), Caroline Dive (CRUK Manchester Institute, UK), Joshua Edel (Imperial College London, UK), Ellen Heitzer (Medical University of Graz, Austria), An Hendrix (Ghent University, Belgium), Huiping Liu (Northwestern University, Chicago), Florent Mouliere (CRUK Manchester Institute, UK), Christina Saura Manich (Vall d’Hebron, Spain), Eleni Tomazou (St Anna CCRI, Austria), Alex Wyatt (Vancouver Prostate Centre, Canada).

Keywords: liquid biopsy, cancer research, oncology, translational research, clinical trials, clinical practice, early detection of cancer, cancer screening techniques, multimodal assays, treatment efficacy vs resistance, treatment toxicity, cell-free DNA, cfRNA, CTCs, extracellular vesicles, extracellular proteins, blood-based analytes, AI in cancer detection and screening. 

Deadlines:  
Travel grant application deadline: 16 September 2024
Abstract submission deadline: 16 September 2024
Registration deadline: 14 October 2024